Form D · Private Equity Fund

Oncology Impact Fund 2, L.P.

Cambridge, MA · CIK 0001817314

Offering snapshot reported Nov 22, 2021 · SEC filing

Reported sold: $327M
Investors reported: 31
Minimum accepted: $0
First sale: Aug 4, 2020

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Nov 22, 2021	Initial	$326,820,000	No comparison	31	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $11.9M
Finders' fees: $0
Form D file number: 021-422030

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
UBS FINANCIAL SERVICES INC.	8174

Source: Form D, filed Nov 22, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ONCOLOGY IMPACT FUND 2, L.P.

Investment adviser: MPM ASSET MANAGEMENT LLC

Gross asset value: $1B
Beneficial owners: 33
ADV minimum commitment: $5M

Reported in Form ADV on Apr 28, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator STANDISH MANAGEMENT, LLC SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG GRAND CAYMAN, Cayman Islands

Custodian JEFFERIES LLC NEW YORK, New York, United States Related to adviser: No

Custodian SILICON VALLEY BANK NEWTON, Massachusetts, United States Related to adviser: No

Prime broker JEFFERIES LLC NEW YORK, New York, United States

Provider details

Annual audit: Yes
Prime brokers: Yes
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

KPMG
PCAOB 185

JEFFERIES LLC
SEC 8-15074

SILICON VALLEY BANK
LEI 549300A7DTSCJLJ33451

JEFFERIES LLC
CRD 2347 · SEC 8-15074

Filing source

Form ADV 2098941 · Apr 28, 2026 · Schedule D 7.B.(1), fund 805-6509560883

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Ansbert Gadicke	Executive
N/A Mpm Oncology Investments 2 Llc	Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

450 Kendall Street
Cambridge, MA, 02142